No Data
No Data
Yimingang Science-B (01541.HK) plans to transfer 0.14 million yuan to transfer 7.0% equity of Yiming Kyle Biomedical Technology (Shanghai).
Yimingang Technology-B (01541.HK) announced on September 13 that on September 13, 2024, the company entered into an equity transfer agreement with Jiaxing Changxin. According to this agreement, Jiaxing Changxin agrees to acquire and the company agrees to transfer the target equity (i.e. 7.0% equity of the target company Yiming Kai'er Biomedical Technology (Shanghai) Co., Ltd.) for a consideration of RMB 0.14 million. Upon completion, the company will hold a 93.0% equity stake in the target company, while the target company will continue to operate as a non-wholly owned subsidiary of the company. The target company was established on January 4, 2024 under Chinese law.
Hong Kong stocks have experienced abnormal movement, with the concept of innovative drugs leading the way. The National Medical Products Administration has accelerated the approval of clinical pharmaceuticals, and many biotech companies have turned losses
Innovative drug concept has the highest increase. As of the time of writing, Akeso (01541) rose 60.42%, to HKD 6.16; Innocare (09926) rose 12.17%, to HKD 63.15; Innocare (09969) rose 6.19%, to HKD 5.83; Kanoa-B (02162) rose 5.56%, to HKD 39.85.
What happened to Yimingang Technology? The stock price has risen over 65% in the past three days.
①What bullish news did Illumina recently announce? ②How do institutions view the recently passed "Biological Safety Act"?
Hong Kong stocks abnormal movement | Ali Health-B (01541) expanded by over 57%, the company reached a cooperation with SynBioTx in early August and received a payment of 15 million US dollars.
Yu Ming Ang Technology-B (01541) has expanded by over 57%, with a cumulative increase of over 80% in two days. As of the time of writing, it has increased by 56.25%, reaching HKD 6, with a turnover of HKD 72.1044 million.
Abnormal statistics of the proportion of ChiNext Stock Connect on September 11th.
Smart Communications Stock Connect Proportion Anomaly Statistics | September 10, 2024
Received further payment under the authorization and cooperation agreement related to IMM2510 and IMM27M with SynBioTx -B.
Gelonghui, September 11th, Yimingang Technology-B(01541.HK) announced that the company has entered into an authorization and cooperation agreement with SynBioTx Inc. ("SynBioTx") on August 1, 2024, and received a down payment based on the authorization and cooperation agreement. Based on the authorization and cooperation agreement, the company has received a recent payment of 5 million US dollars from SynBioTx.
No Data
No Data